Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BRIDGEBIO PHARMA, INC.

(BBIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 4 3318 7161 3171 317-
Enterprise Value (EV)1 3 8778 8371 6532 2142 505
P/E ratio -14,1x-18,7x-2,41x-2,22x-2,19x
Yield -----
Capitalization / Revenue 107x1 057x16,8x15,8x23,1x
EV / Revenue 95,6x1 071x21,1x26,5x43,9x
EV / EBITDA -14,6x-18,6x-3,01x-3,87x-4,30x
Price to Book 9,02x151x1,25x3,06x-
Nbr of stocks (in thousands) 123 575122 568147 192147 192-
Reference price (USD) 35,171,18,958,958,95
Announcement Date 03/02/202002/25/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 -40,68,2578,383,657,1
EBITDA1 --266-474-549-571-583
Operating profit (EBIT)1 --266-474-541-558-609
Operating Margin --656%-5 752%-692%-668%-1 067%
Pre-Tax Profit (EBT)1 --289-505-562-632-660
Net income1 -131-261-449-534-583-650
Net margin --642%-5 440%-682%-697%-1 139%
EPS2 -8,01-2,48-3,80-3,72-4,02-4,08
Dividend per Share2 ------
Announcement Date 05/24/201903/02/202002/25/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 0,4654,02,3421,63,113,68
EBITDA1 -168-94,0-149-127-152-153
Operating profit (EBIT)1 -168-94,0-149-130-151-153
Operating Margin -36 256%-174%-6 378%-603%-4 858%-4 152%
Pre-Tax Profit (EBT)1 -171-102-161-126-163-167
Net income1 -163-96,3-156-119-168-172
Net margin -35 298%-178%-6 653%-551%-5 389%-4 691%
EPS2 -1,18-0,66-1,06-0,85-1,06-1,07
Dividend per Share ------
Announcement Date 05/06/202108/05/202111/04/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 --1213368961 187
Net Cash position1 -454----
Leverage (Debt / EBITDA) -1,71x-0,26x-0,61x-1,57x-2,04x
Free Cash Flow1 --256-407-390-503-455
ROE (Net Profit / Equities) --72,1%-192%-105%-97,4%-347%
Shareholders' equity1 -362233507598187
ROA (Net Profit / Asset) --47,5%-67,2%-50,9%-49,2%-78,3%
Assets1 -5486681 0481 185831
Book Value Per Share2 -3,890,477,172,92-
Cash Flow per Share2 ---3,39-4,07-3,90-
Capex1 -2,647,527,745,855,96
Capex / Sales -6,50%91,1%9,89%7,00%10,4%
Announcement Date 05/24/201903/02/202002/25/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 1 317 369 536
Net sales (USD) 8 249 000
Number of employees 391
Sales / Employee (USD) 21 097
Avg. Exchange 20 sessions (USD) 70 514 091
Average Daily Capital Traded 5,35%
EPS & Dividend